ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 724 filers reported holding ASTRAZENECA PLC in Q3 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,151,250 | +35.0% | 14,762 | +17.3% | 0.07% | +44.9% |
| Q1 2024 | $852,534 | +0.7% | 12,584 | +0.1% | 0.05% | -10.9% |
| Q4 2023 | $846,594 | +12.6% | 12,570 | +13.2% | 0.06% | +1.9% |
| Q3 2023 | $751,696 | +12.8% | 11,100 | +19.2% | 0.05% | +12.5% |
| Q2 2023 | $666,664 | +3.0% | 9,315 | -0.2% | 0.05% | +2.1% |
| Q1 2023 | $647,516 | +1.6% | 9,329 | -0.8% | 0.05% | -2.1% |
| Q4 2022 | $637,417 | +18.9% | 9,401 | +46.2% | 0.05% | +9.1% |
| Q3 2022 | $536,000 | +77.5% | 6,429 | +40.7% | 0.04% | +76.0% |
| Q2 2022 | $302,000 | +1.0% | 4,568 | +1.6% | 0.02% | +25.0% |
| Q1 2022 | $299,000 | +12.8% | 4,496 | +2.5% | 0.02% | +17.6% |
| Q4 2021 | $265,000 | -2.9% | 4,385 | -3.7% | 0.02% | -5.6% |
| Q3 2021 | $273,000 | +32.5% | 4,554 | +32.3% | 0.02% | +28.6% |
| Q2 2021 | $206,000 | -10.8% | 3,443 | -9.6% | 0.01% | -30.0% |
| Q3 2020 | $231,000 | +12.7% | 3,807 | -1.9% | 0.02% | +5.3% |
| Q2 2020 | $205,000 | – | 3,880 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |